Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to Vanderbilt, Morehouse, and More

Premium

NIH Grants in Proteomics, March 15 to April 17

Project Title: Regulatory Pathways of SR Protein Kinases
Contact Principal Investigator: Joseph Adams
Organization Name: University of California San Diego
Project Start Date: Feb. 1, 2004
Project End Date: Dec. 31, 2016
FY Total Cost: $310,000


Project Title: Clk Kinases and Splicing Regulation
Contact Principal Investigator: Joseph Adams
Organization Name: University of California San Diego
Project Start Date: June 1, 2012
Project End Date: March 31, 2016
FY Total Cost: $265,050


Project Title: Induced Pluripotent Stem Cells for the Study of Long QT Syndrome
Contact Principal Investigator: Eric Adler
Organization Name: University of California San Diego
Project Start Date: April 18, 2011
Project End Date: March 31, 2016
FY Total Cost: $133,650


Project Title: Molecular and Cellular Basis of Obesity Core
Contact Principal Investigator: David Bernlohr
Organization Name: University of Minnesota
Project Start Date: NA
Project End Date: NA
FY Total Cost: $262,935


Project Title: Instrumentation Development: MS Array for Quantitative Proteomics
Contact Principal Investigator: James Bruce
Organization Name: University of Washington
Project Start Date: April 1, 2011
Project End Date: March 31, 2015
FY Total Cost: $294,110


Project Title: Dissecting the Cytoplasmic Interactome of The Alpha7 NAChR Subtype
Contact Principal Investigator: William Brucker
Organization Name: Brown University
Project Start Date: April 1, 2008
Project End Date: March 31, 2014
FY Total Cost: $47,232


Project Title: Chemoproteomic Methods for Serine Hydrolase Inhibitor Development
Contact Principal Investigator: Benjamin Cravatt
Organization Name: Scripps Research Institute
Project Start Date: April 1, 2012
Project End Date: March 31, 2017
FY Total Cost: $443,210


Project Title: Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
Contact Principal Investigator: Todd Fehniger
Organization Name: Washington University
Project Start Date: April 26, 2009
Project End Date: March 31, 2014
FY Total Cost: $116,503


Project Title: Proteomics Facility Core
Contact Principal Investigator: Peter Guengerich
Organization Name: Vanderbilt University Medical Central
Project Start Date: NA
Project End Date: NA
FY Total Cost: $112,418


Project Title: Global Characterization of Ubiquitin Information Networks with Mass Spectrometry
Contact Principal Investigator: Steven Gygi
Organization Name: Harvard University Medical School
Project Start Date: May 15, 2003
Project End Date: Feb. 28, 2017
FY Total Cost: $457,282


Project Title: A Molecular Toolkit for Single-Molecule Protein Sequencing
Contact Principal Investigator: James Havranek
Organization Name: Washington University
Project Start Date: June 1, 2012
Project End Date: March 31, 2017
FY Total Cost: $259,920


Project Title: Cardioprotective Mechanisms of HDL
Contact Principal Investigator: Jay Heinecke
Organization Name: University of Washington
Project Start Date: April 16, 2012
Project End Date: March 31, 2016
FY Total Cost: $390,938


Project Title: Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling Network
Contact Principal Investigator: Robert Husson
Organization Name: Childrens Hospital Corporation
Project Start Date: April 16, 2012
Project End Date: March 31, 2017
FY Total Cost: $1,093,417


Project Title: Reactive Species in Vascular Disease: Mechanisms of Injury
Contact Principal Investigator: Harry Ischiropoulos
Organization Name: Children's Hospital of Philadelphia
Project Start Date: Sept. 5, 1997
Project End Date: March 31, 2015
FY Total Cost: $376,875

Project Title: Accelerated Protein Signaling Signatures
Contact Principal Investigator: Jacob Jaffe
Organization Name: Broad Institute
Project Start Date: April 1, 2013
Project End Date: Aug. 31, 2013
FY Total Cost: $214,747


Project Title: Analysis of Protein Dynamics in C. Elegans by MLC/MS/MS
Contact Principal Investigator: Michael MacCoss
Organization Name: University of Washington
Project Start Date: April 15, 2006
Project End Date: Nov. 30, 2013
FY Total Cost: $181,354


Project Title: A Systems Approach to Stress Biology and Proteostasis Networks
Contact Principal Investigator: Richard Morimoto
Organization Name: Northwestern University
Project Start Date: April 1, 1987
Project End Date: March 31, 2014
FY Total Cost: $489,759


Project Title: Population-Based Proteomic Investigation of Type 2 Diabetes Mellitus
Contact Principal Investigator: Randall Nelson
Organization Name: Arizona State University-Tempe Campus
Project Start Date: March 1, 2010
Project End Date: Feb. 28, 2015
FY Total Cost: $516,727


Project Title: Mitochondrial Dysfunction in Cardiac Hypertrophy and Failure
Contact Principal Investigator: Brian O'Rourke,
Organization Name: Johns Hopkins University
Project Start Date: May 1, 2010
Project End Date: March 31, 2014
FY Total Cost: $614,809


Project Title: Network Analysis of Signal Transduction
Contact Principal Investigator: Norbert Perrimon,
Organization Name: Harvard University Medical School
Project Start Date: April 15, 2010
Project End Date: March 31, 2015
FY Total Cost: $431,246


Project Title: Genetic Information Transfer to Hematopoietic Cells: Role of Microvesicles
Contact Principal Investigator: Peter Quesenberry
Organization Name: Rhode Island Hospital
Project Start Date: April 1, 2011
Project End Date: March 31, 2015
FY Total Cost: $347,625


Project Title: Mitochondrial-Targeted Antioxidants, Aging and AZT in Skeletal Muscle Dysfunction
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $273,442


Project Title: Proteomics
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: NA
Project End Date: NA
FY Total Cost: $181,297


Project Title: Mitochondrial Antioxidants, Aging and Healthspan
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: Aug. 15, 1997
Project End Date: Feb. 29, 2016
FY Total Cost: $1,681,304


Project Title: Cardiomyocyte Mitochondria and Mtros in Cardiac Aging, Hypertrophy and Failure
Contact Principal Investigator: Peter Rabinovitch
Organization Name: University of Washington
Project Start Date: May 1, 2010
Project End Date: March 31, 2014
FY Total Cost: $570,226


Project Title: Automated High-Throughput Estimation and Modeling of Protein Network Distributions
Contact Principal Investigator: Gustavo Rohde
Organization Name: Carnegie-Mellon University
Project Start Date: April 1, 2010
Project End Date: March 31, 2014
FY Total Cost: $266,774


Project Title: Engineered Proteases for Proteomics
Contact Principal Investigator: Biao Ruan,
Organization Name: Potomac Affinity Proteins
Project Start Date: May 1, 2009
Project End Date: Jan. 31, 2015
FY Total Cost: $339,201


Project Title: Systems Biology Facility Core
Contact Principal Investigator: James Swenberg
Organization Name: University of North Carolina Chapel Hill
Project Start Date: NA
Project End Date: NA
FY Total Cost: $178,188


Project Title: Polycomb Group Proteins as Epigenetic Mediators of Brain Ischemic Tolerance
Contact Principal Investigator: An Zhou
Organization Name: Morehouse School of Medicine
Project Start Date: April 1, 2012
Project End Date: March 31, 2016
FY Total Cost: $278,578

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.